Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Medroxyprogesterone

Copy Product Info
😃Good
Catalog No. T5040Cas No. 520-85-4

Medroxyprogesterone is used in the treatment of renal carcinoma. It is a synthetic progestational hormone used in veterinary practice as an estrus regulator.

Medroxyprogesterone

Medroxyprogesterone

Copy Product Info
😃Good
Purity: 99.51%
Catalog No. T5040Cas No. 520-85-4
Medroxyprogesterone is used in the treatment of renal carcinoma. It is a synthetic progestational hormone used in veterinary practice as an estrus regulator.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
50 mg$33In StockIn Stock
100 mg$50In StockIn Stock
500 mg$148In StockIn Stock
1 g$197-In Stock
1 mL x 10 mM (in DMSO)$55In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.51%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Medroxyprogesterone AI Summary
Medroxyprogesterone exhibits a diverse range of bioactivities, including significant effects on human MRP2-mediated transport with an activity level of 111.0%. The compound demonstrates inhibitory potency against various targets, such as Tau fibril formation, malaria parasite plastid function, and several viruses including Ebola, Lassa, Hepatitis C, and Foot and Mouth Disease virus. It notably inhibits CYP450 2C19 enzyme, glucocorticoid, androgen, and progesterone receptor binding, indicating its potential as an enzyme inhibitor and ligand binder. In terms of hepatotoxicity, Medroxyprogesterone shows moderate to severe liver toxicity with potential manifestations like elevated serum enzyme levels, severe clinical signs, cytolytic and cholestatic liver toxicity, severe hepatitis, hepatomegaly, and granulomatous liver disease, along with a combined hepatotoxic DILIps score of 5.0. Specific liver injury induction severity is classified at 2.0. The compound further indicates differential effects on cell viability, maintaining growth in HEK293T and U2OS cells but showing no growth in human fibroblast cells. It has varied antifungal and antibacterial activity, with moderate effects against Pseudomonas aeruginosa and Acinetobacter baumannii. In the context of antiviral activities, Medroxyprogesterone inhibits SARS-CoV-2 in HRCE cells, exhibits 7.702% inhibition of SARS-CoV-2 3CL-Pro protease at 20µM, and shows mild inhibition of virus-induced cytotoxicity in Caco-2 and VERO-6 cells. Additionally, it affects thermal stability of various protein domains and demonstrates an HDAC6 inhibition potential and a volume of distribution at steady state of Vdss = 4.66 L.kg-1, with a high fraction unbound in human plasma (logFu = 0.1)..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
Medroxyprogesterone is used in the treatment of renal carcinoma. It is a synthetic progestational hormone used in veterinary practice as an estrus regulator.
Chemical Properties
Molecular Weight344.49
FormulaC22H32O3
Cas No.520-85-4
Smiles[H][C@@]12CC[C@](O)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)CC[C@]12C
Relative Density.1.13g/cm3
Storage & Solubility Information
Storagekeep away from moisture | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 71.43 mg/mL (207.35 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+90% Corn Oil: 2.5 mg/mL (7.26 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.9028 mL14.5142 mL29.0284 mL145.1421 mL
5 mM0.5806 mL2.9028 mL5.8057 mL29.0284 mL
10 mM0.2903 mL1.4514 mL2.9028 mL14.5142 mL
20 mM0.1451 mL0.7257 mL1.4514 mL7.2571 mL
50 mM0.0581 mL0.2903 mL0.5806 mL2.9028 mL
100 mM0.0290 mL0.1451 mL0.2903 mL1.4514 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Medroxyprogesterone | purchase Medroxyprogesterone | Medroxyprogesterone cost | order Medroxyprogesterone | Medroxyprogesterone chemical structure | Medroxyprogesterone formula | Medroxyprogesterone molecular weight